Tuberculosis (TB) is still the deadliest infectious disease worldwide, killing over 4.000 people every day. This is unnecessary as TB can be cured with appropriate treatment. A number of barriers however, prevent patients from recovering from this disease, including long and complicated treatment regimens that involve the daily intake of medicines over the course of 6-24 months.

By leveraging today’s smart information and (mobile) communication technologies the ASCENT project (Adherence Support Coalition to End TB) aims to support TB patients with their treatment in a modern and more effective way through the use of digital adherence technologies such as smart pill boxes, medication sleeves and video supported treatment.

By generating evidence, establishing a global market and engaging stakeholders, ASCENT aims to make future scale up possible so that these digital innovations can be available to all TB patients worldwide.

The ASCENT HQ Team is closely monitoring the current situation in Ukraine, especially with regard to our projects and staff members in the region. We have regular contact with PATH, who is responsible for the implementation of the ASCENT project in Ukraine, on the safety and security of the ASCENT staff in Ukraine. They are in our thoughts and we wish them strength in this difficult situation.

Kristian van Kalmthout, ASCENT project director or Kelly Schut, ASCENT grant manager

If you have any questions on external project communication, please address your questions to Lilian Polderman, ASCENT communication manager.